ArticleBiomedicines2022

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide.

Katharina Otte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.